Achieve life sciences to participate in the btig virtual biotechnology conference

Seattle and vancouver, british columbia, july 29, 2025 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced that the company will participate in the btig virtual biotechnology conference being held july 29-30, 2025.
ACHV Ratings Summary
ACHV Quant Ranking